International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman diseaseFrits van Rhee, David C. Fajgenbaum, Peter M. Voorhees et al.|Blood|2018Cited by 421
International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman diseaseFrits van Rhee, David C. Fajgenbaum, Éric Oksenhendler et al.|Blood Advances|2020Cited by 218
Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer RiskIris Kramer, Margit Riis, Annelie Augustinsson et al.|The American Journal of Human Genetics|2020Cited by 72
ACCELERATE: A Patient-Powered Natural History Study Design Enabling Clinical and Therapeutic Discoveries in a Rare DisorderSheila K. Pierson, David C. Fajgenbaum, Johnson S. Khor et al.|Cell Reports Medicine|2020Cited by 33
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registrySheila K. Pierson, David C. Fajgenbaum, Joshua D. Brandstadter et al.|Blood Advances|2025Cited by 19